These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Three phenotypes of obstructive lung disease in the elderly. Jo KW; Ra SW; Chae EJ; Seo JB; Kim NK; Lee JH; Kim EK; Lee YK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lim SY; Shin TR; Yoon HI; Sheen SS; Lee JS; Lee SD; Oh YM Int J Tuberc Lung Dis; 2010 Nov; 14(11):1481-8. PubMed ID: 20937191 [TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Yernault JC Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959 [No Abstract] [Full Text] [Related]
28. [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases]. Dalsgarth OJ; Vestbo J; Lange P Ugeskr Laeger; 2000 Jan; 162(4):529-32. PubMed ID: 10697460 [TBL] [Abstract][Full Text] [Related]
29. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745 [TBL] [Abstract][Full Text] [Related]
30. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553 [TBL] [Abstract][Full Text] [Related]
31. Intranasal corticosteroid therapy and bronchial hyperresponsiveness in the unified airway. Currie GP; Lee DK Ann Allergy Asthma Immunol; 2004 Aug; 93(2):206; author reply 206-7. PubMed ID: 15328684 [No Abstract] [Full Text] [Related]
32. [Diagnosis of bronchial asthma and chronic obstructive lung disease by the family physician. Ad hoc consensus group 'Diagnosis of asthma/chronic obstructive lung disease by the family physician']. van Schayck CP Ned Tijdschr Geneeskd; 1995 Sep; 139(39):1966-71. PubMed ID: 7477538 [No Abstract] [Full Text] [Related]
33. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD). Sandek K; Bratel T; Lagerstrand L Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957 [TBL] [Abstract][Full Text] [Related]
37. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. Niewoehner DE; Erbland ML; Deupree RH; Collins D; Gross NJ; Light RW; Anderson P; Morgan NA N Engl J Med; 1999 Jun; 340(25):1941-7. PubMed ID: 10379017 [TBL] [Abstract][Full Text] [Related]
38. Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease. Calverley PM Thorax; 1999 Jan; 54(1):3-4. PubMed ID: 10343623 [No Abstract] [Full Text] [Related]
39. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease. Hahn DL N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868 [No Abstract] [Full Text] [Related]
40. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. John M; Bosse S; Oltmanns U; Schumacher A; Witt C Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]